secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
CIK:        0001335105
Form:       8-K
Filed at:   2023-05-30T23:59:59+00:00
Accession:  0001493152-23-019495
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Lixte Biotechnology shareholders approve reverse stock split up to 1-for-10
---------------------------------------------------------------------------

- Stockholders approved granting Board authority to effect a reverse stock split at a ratio up to 1-for-10.
- Exact split ratio to be determined by Board in its sole discretion.
- Votes: 11,122,681 for, 577,844 against, 2,841 abstentions, 275,345 broker non-votes.
- Special meeting held May 26, 2023; amendment to Certificate of Incorporation approved.
- Company has 16,659,093 shares of common stock outstanding and entitled to vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1335105/000149315223019495/0001493152-23-019495-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1335105/000149315223019495/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-019495

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer